English
简体中文
Total: £ 56.28
Published Date: 2025-10-17 | Pages: 121 | Tables: 117 | Medical Care
The global Cell Expansion Service market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.
Cell Expansion Service refers to cell expansion services provided by contract research organizations (CROs) or biotechnology companies. This service is designed to expand a small amount of initial cells to meet large-scale cell needs in clinical research, cell therapy, drug screening or gene therapy. Cell expansion services are often used in the production of stem cells, immune cells (such as T cells, CAR-T cells), mesenchymal stem cells (MSCs) and other therapeutic cells to ensure that sufficient quantity and high quality cells can be used for downstream applications.
From a downstream perspective, Cell Therapy accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Cell Expansion Service leading manufacturers including Lonza, Thermo Fisher Scientific, JangoCell, BioIVT, PromoCell, Cytiva, Creative Biolabs, Trenzyme, Cytion, Cell Culture Company, etc., dominate supply; the top five capture approximately % of global revenue, with Lonza leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Cell Expansion Service market across value chain. It analyzes historical revenue data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies market size, growth rates, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries, detailing dominant products, competitive landscape, and downstream demand trends.
Critical competitive intelligence profiles players—revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise Industry‑chain overview maps upstream, middlestream, and downstream distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation
By Company
Lonza
Thermo Fisher Scientific
JangoCell
BioIVT
PromoCell
Cytiva
Creative Biolabs
Trenzyme
Cytion
Cell Culture Company
Segment by Type
Immuno Cell Expansion
Stem Cell Expansion
Others
Segment by Application
Cell Therapy
Clinical Trials
Others
Sales by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
Japan
South Korea
India
Australia
Vietnam
Indonesia
Malaysia
Philippines
Singapore
Rest of Asia
Europe
Germany
U.K.
France
Italy
Spain
Benelux
Russia
Rest of Europe
Central and South America
Brazil
Argentina
Rest of South America
Middle East & Africa
GCC Countries
Egypt
Israel
South Africa
Rest of MEA
Chapter Outline
Chapter 1: Defines the Cell Expansion Service study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the player landscape—ranks by revenue and profitability, details Player performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates market size by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down market size by Type, by Application and country, profiles key players and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional market by Type, by Application and players, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies market size by Type, by Application, and region/country, profiles top players, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures market size by Type, by Application, and country, profiles top players, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates market size by Type, by Application, and country, profiles key players, and outlines investment prospects and market hurdles
Chapter 11: Profiles players in depth—details product specs, revenue, margins; Top-tier players 2024 sales breakdowns by Product type, by Application, by region SWOT analysis, and recent strategic developments.
Chapter 12: Industry chain—analyses upstream, cost drivers, plus downstream channels.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 14: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter 5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Capitalize on the projected billion‑dollar opportunity with data‑driven regional and segment tactics (Chapter 12-14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Study Coverage
1.1 Introduction to Cell Expansion Service: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Cell Expansion Service Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Immuno Cell Expansion
1.2.3 Stem Cell Expansion
1.2.4 Others
1.3 Market Segmentation by Application
1.3.1 Global Cell Expansion Service Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Cell Therapy
1.3.3 Clinical Trials
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Cell Expansion Service Revenue Estimates and Forecasts 2020-2031
2.2 Global Cell Expansion Service Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020-2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.2.4 Emerging Market Focus: Growth Drivers & Investment Trends
3 Competition by Players
3.1 Global Cell Expansion Service Player Revenue Rankings and Profitability
3.1.1 Global Revenue (Value) by Players (2020-2025)
3.1.2 Global Key Player Revenue Ranking (2023 vs. 2024)
3.1.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.1.4 Gross Margin by Top Player (2020 VS 2024)
3.2 Global Cell Expansion Service Companies Headquarters and Service Footprint
3.3 Main Product Type Market Size by Players
3.3.1 Immuno Cell Expansion Market Size by Players
3.3.2 Stem Cell Expansion Market Size by Players
3.3.3 Others Market Size by Players
3.4 Global Cell Expansion Service Market Concentration and Dynamics
3.4.1 Global Market Concentration (CR5 and HHI)
3.4.2 Entrant/Exit Impact Analysis
3.4.3 Strategic Moves: M&A, Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Cell Expansion Service Revenue Trends by Type
4.1.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.1.2 Global Revenue Market Share by Type (2020-2031)
4.2 Key Product Attributes and Differentiation
4.3 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.3.1 High-Growth Niches and Adoption Drivers
4.3.2 Profitability Hotspots and Cost Drivers
4.3.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Cell Expansion Service Revenue by Application
5.1.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.1.2 Revenue Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Downstream Customer Analysis
5.2.1 Top Customers by Region
5.2.2 Top Customers by Application
6 North America
6.1 North America Market Size (2020-2031)
6.2 North America Key Players Revenue in 2024
6.3 North America Cell Expansion Service Market Size by Type (2020-2031)
6.4 North America Cell Expansion Service Market Size by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Cell Expansion Service Market Size by Country
6.6.1 North America Revenue Trends by Country
6.6.2 US
6.6.3 Canada
6.6.4 Mexico
7 Europe
7.1 Europe Market Size (2020-2031)
7.2 Europe Key Players Revenue in 2024
7.3 Europe Cell Expansion Service Market Size by Type (2020-2031)
7.4 Europe Cell Expansion Service Market Size by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Cell Expansion Service Market Size by Country
7.6.1 Europe Revenue Trends by Country
7.6.2 Germany
7.6.3 France
7.6.4 U.K.
7.6.5 Italy
7.6.6 Russia
8 Asia-Pacific
8.1 Asia-Pacific Market Size (2020-2031)
8.2 Asia-Pacific Key Players Revenue in 2024
8.3 Asia-Pacific Cell Expansion Service Market Size by Type (2020-2031)
8.4 Asia-Pacific Cell Expansion Service Market Size by Application (2020-2031)
8.5 Asia-Pacific Growth Accelerators and Market Barriers
8.6 Asia-Pacific Cell Expansion Service Market Size by Region
8.6.1 Asia-Pacific Revenue Trends by Region
8.7 China
8.8 Japan
8.9 South Korea
8.10 Australia
8.11 India
8.12 Southeast Asia
8.12.1 Indonesia
8.12.2 Vietnam
8.12.3 Malaysia
8.12.4 Philippines
8.12.5 Singapore
9 Central and South America
9.1 Central and South America Market Size (2020-2031)
9.2 Central and South America Key Players Revenue in 2024
9.3 Central and South America Cell Expansion Service Market Size by Type (2020-2031)
9.4 Central and South America Cell Expansion Service Market Size by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Cell Expansion Service Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Market Size (2020-2031)
10.2 Middle East and Africa Key Players Revenue in 2024
10.3 Middle East and Africa Cell Expansion Service Market Size by Type (2020-2031)
10.4 Middle East and Africa Cell Expansion Service Market Size by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Cell Expansion Service Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Israel
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Lonza
11.1.1 Lonza Corporation Information
11.1.2 Lonza Business Overview
11.1.3 Lonza Cell Expansion Service Product Features and Attributes
11.1.4 Lonza Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.1.5 Lonza Cell Expansion Service Revenue by Product in 2024
11.1.6 Lonza Cell Expansion Service Revenue by Application in 2024
11.1.7 Lonza Cell Expansion Service Revenue by Geographic Area in 2024
11.1.8 Lonza Cell Expansion Service SWOT Analysis
11.1.9 Lonza Recent Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Corporation Information
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Cell Expansion Service Product Features and Attributes
11.2.4 Thermo Fisher Scientific Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.2.5 Thermo Fisher Scientific Cell Expansion Service Revenue by Product in 2024
11.2.6 Thermo Fisher Scientific Cell Expansion Service Revenue by Application in 2024
11.2.7 Thermo Fisher Scientific Cell Expansion Service Revenue by Geographic Area in 2024
11.2.8 Thermo Fisher Scientific Cell Expansion Service SWOT Analysis
11.2.9 Thermo Fisher Scientific Recent Developments
11.3 JangoCell
11.3.1 JangoCell Corporation Information
11.3.2 JangoCell Business Overview
11.3.3 JangoCell Cell Expansion Service Product Features and Attributes
11.3.4 JangoCell Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.3.5 JangoCell Cell Expansion Service Revenue by Product in 2024
11.3.6 JangoCell Cell Expansion Service Revenue by Application in 2024
11.3.7 JangoCell Cell Expansion Service Revenue by Geographic Area in 2024
11.3.8 JangoCell Cell Expansion Service SWOT Analysis
11.3.9 JangoCell Recent Developments
11.4 BioIVT
11.4.1 BioIVT Corporation Information
11.4.2 BioIVT Business Overview
11.4.3 BioIVT Cell Expansion Service Product Features and Attributes
11.4.4 BioIVT Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.4.5 BioIVT Cell Expansion Service Revenue by Product in 2024
11.4.6 BioIVT Cell Expansion Service Revenue by Application in 2024
11.4.7 BioIVT Cell Expansion Service Revenue by Geographic Area in 2024
11.4.8 BioIVT Cell Expansion Service SWOT Analysis
11.4.9 BioIVT Recent Developments
11.5 PromoCell
11.5.1 PromoCell Corporation Information
11.5.2 PromoCell Business Overview
11.5.3 PromoCell Cell Expansion Service Product Features and Attributes
11.5.4 PromoCell Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.5.5 PromoCell Cell Expansion Service Revenue by Product in 2024
11.5.6 PromoCell Cell Expansion Service Revenue by Application in 2024
11.5.7 PromoCell Cell Expansion Service Revenue by Geographic Area in 2024
11.5.8 PromoCell Cell Expansion Service SWOT Analysis
11.5.9 PromoCell Recent Developments
11.6 Cytiva
11.6.1 Cytiva Corporation Information
11.6.2 Cytiva Business Overview
11.6.3 Cytiva Cell Expansion Service Product Features and Attributes
11.6.4 Cytiva Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.6.5 Cytiva Recent Developments
11.7 Creative Biolabs
11.7.1 Creative Biolabs Corporation Information
11.7.2 Creative Biolabs Business Overview
11.7.3 Creative Biolabs Cell Expansion Service Product Features and Attributes
11.7.4 Creative Biolabs Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.7.5 Creative Biolabs Recent Developments
11.8 Trenzyme
11.8.1 Trenzyme Corporation Information
11.8.2 Trenzyme Business Overview
11.8.3 Trenzyme Cell Expansion Service Product Features and Attributes
11.8.4 Trenzyme Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.8.5 Trenzyme Recent Developments
11.9 Cytion
11.9.1 Cytion Corporation Information
11.9.2 Cytion Business Overview
11.9.3 Cytion Cell Expansion Service Product Features and Attributes
11.9.4 Cytion Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.9.5 Cytion Recent Developments
11.10 Cell Culture Company
11.10.1 Cell Culture Company Corporation Information
11.10.2 Cell Culture Company Business Overview
11.10.3 Cell Culture Company Cell Expansion Service Product Features and Attributes
11.10.4 Cell Culture Company Cell Expansion Service Revenue and Gross Margin (2020-2025)
11.10.5 Company Ten Recent Developments
12 Cell Expansion ServiceIndustry Chain Analysis
12.1 Cell Expansion Service Industry Chain
12.2 Upstream Analysis
12.2.1 Upstream Key Suppliers
12.3 Middlestream Analysis
12.4 Downstream Sales Model and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Cell Expansion Service Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Cell Expansion Service Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
List of Tables
Table 1. Global Cell Expansion Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global Cell Expansion Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global Cell Expansion Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global Cell Expansion Service Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Cell Expansion Service Revenue by Region (2026-2031) & (US$ Million)
Table 6. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 7. Global Cell Expansion Service Revenue by Players (2020-2025) & (US$ Million)
Table 8. Global Cell Expansion Service Revenue Market Share by Players (2020-2025)
Table 9. Global Key Players’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 10. Global Cell Expansion Service by Player Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cell Expansion Service as of 2024)
Table 11. Global Cell Expansion Service Average Gross Margin (%) by Player (2020 VS 2024)
Table 12. Global Cell Expansion Service Companies Headquarters
Table 13. Global Cell Expansion Service Market Concentration Ratio (CR5 and HHI)
Table 14. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 15. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 16. Global Cell Expansion Service Revenue by Type (2020-2025) & (US$ Million)
Table 17. Global Cell Expansion Service Revenue by Type (2026-2031) & (US$ Million)
Table 18. Key Product Attributes and Differentiation
Table 19. Global Cell Expansion Service Revenue by Application (2020-2025) & (US$ Million)
Table 20. Global Cell Expansion Service Revenue by Application (2026-2031) & (US$ Million)
Table 21. Cell Expansion Service High-Growth Sectors Demand CAGR (2024-2031)
Table 22. Top Customers by Region
Table 23. Top Customers by Application
Table 24. North America Cell Expansion Service Growth Accelerators and Market Barriers
Table 25. North America Cell Expansion Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 26. Europe Cell Expansion Service Growth Accelerators and Market Barriers
Table 27. Europe Cell Expansion Service Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 28. Asia-Pacific Cell Expansion Service Growth Accelerators and Market Barriers
Table 29. Asia-Pacific Cell Expansion Service Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 30. Central and South America Cell Expansion Service Investment Opportunities and Key Challenges
Table 31. Central and South America Cell Expansion Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 32. Middle East and Africa Cell Expansion Service Investment Opportunities and Key Challenges
Table 33. Middle East and Africa Cell Expansion Service Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 34. Lonza Corporation Information
Table 35. Lonza Description and Major Businesses
Table 36. Lonza Product Features and Attributes
Table 37. Lonza Revenue (US$ Million) and Gross Margin (2020-2025)
Table 38. Lonza Revenue Proportion by Product in 2024
Table 39. Lonza Revenue Proportion by Application in 2024
Table 40. Lonza Revenue Proportion by Geographic Area in 2024
Table 41. Lonza Cell Expansion Service SWOT Analysis
Table 42. Lonza Recent Developments
Table 43. Thermo Fisher Scientific Corporation Information
Table 44. Thermo Fisher Scientific Description and Major Businesses
Table 45. Thermo Fisher Scientific Product Features and Attributes
Table 46. Thermo Fisher Scientific Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Thermo Fisher Scientific Revenue Proportion by Product in 2024
Table 48. Thermo Fisher Scientific Revenue Proportion by Application in 2024
Table 49. Thermo Fisher Scientific Revenue Proportion by Geographic Area in 2024
Table 50. Thermo Fisher Scientific Cell Expansion Service SWOT Analysis
Table 51. Thermo Fisher Scientific Recent Developments
Table 52. JangoCell Corporation Information
Table 53. JangoCell Description and Major Businesses
Table 54. JangoCell Product Features and Attributes
Table 55. JangoCell Revenue (US$ Million) and Gross Margin (2020-2025)
Table 56. JangoCell Revenue Proportion by Product in 2024
Table 57. JangoCell Revenue Proportion by Application in 2024
Table 58. JangoCell Revenue Proportion by Geographic Area in 2024
Table 59. JangoCell Cell Expansion Service SWOT Analysis
Table 60. JangoCell Recent Developments
Table 61. BioIVT Corporation Information
Table 62. BioIVT Description and Major Businesses
Table 63. BioIVT Product Features and Attributes
Table 64. BioIVT Revenue (US$ Million) and Gross Margin (2020-2025)
Table 65. BioIVT Revenue Proportion by Product in 2024
Table 66. BioIVT Revenue Proportion by Application in 2024
Table 67. BioIVT Revenue Proportion by Geographic Area in 2024
Table 68. BioIVT Cell Expansion Service SWOT Analysis
Table 69. BioIVT Recent Developments
Table 70. PromoCell Corporation Information
Table 71. PromoCell Description and Major Businesses
Table 72. PromoCell Product Features and Attributes
Table 73. PromoCell Revenue (US$ Million) and Gross Margin (2020-2025)
Table 74. PromoCell Revenue Proportion by Product in 2024
Table 75. PromoCell Revenue Proportion by Application in 2024
Table 76. PromoCell Revenue Proportion by Geographic Area in 2024
Table 77. PromoCell Cell Expansion Service SWOT Analysis
Table 78. PromoCell Recent Developments
Table 79. Cytiva Corporation Information
Table 80. Cytiva Description and Major Businesses
Table 81. Cytiva Product Features and Attributes
Table 82. Cytiva Revenue (US$ Million) and Gross Margin (2020-2025)
Table 83. Cytiva Recent Developments
Table 84. Creative Biolabs Corporation Information
Table 85. Creative Biolabs Description and Major Businesses
Table 86. Creative Biolabs Product Features and Attributes
Table 87. Creative Biolabs Revenue (US$ Million) and Gross Margin (2020-2025)
Table 88. Creative Biolabs Recent Developments
Table 89. Trenzyme Corporation Information
Table 90. Trenzyme Description and Major Businesses
Table 91. Trenzyme Product Features and Attributes
Table 92. Trenzyme Revenue (US$ Million) and Gross Margin (2020-2025)
Table 93. Trenzyme Recent Developments
Table 94. Cytion Corporation Information
Table 95. Cytion Description and Major Businesses
Table 96. Cytion Product Features and Attributes
Table 97. Cytion Revenue (US$ Million) and Gross Margin (2020-2025)
Table 98. Cytion Recent Developments
Table 99. Cell Culture Company Corporation Information
Table 100. Cell Culture Company Description and Major Businesses
Table 101. Cell Culture Company Product Features and Attributes
Table 102. Cell Culture Company Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Cell Culture Company Recent Developments
Table 104. Raw Materials Key Suppliers
Table 105. Distributors List
Table 106. Market Trends and Market Evolution
Table 107. Market Drivers and Opportunities
Table 108. Market Challenges, Risks, and Restraints
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Cell Expansion Service Product Picture
Figure 2. Global Cell Expansion Service Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Immuno Cell Expansion Product Picture
Figure 4. Stem Cell Expansion Product Picture
Figure 5. Others Product Picture
Figure 6. Global Cell Expansion Service Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 7. Cell Therapy
Figure 8. Clinical Trials
Figure 9. Others
Figure 10. Cell Expansion Service Report Years Considered
Figure 11. Global Cell Expansion Service Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 13. Global Cell Expansion Service Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 14. Global Cell Expansion Service Revenue Market Share by Region (2020-2031)
Figure 15. Global Cell Expansion Service Revenue Market Share Ranking (2024)
Figure 16. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 17. Immuno Cell Expansion Revenue Market Share by Player in 2024
Figure 18. Stem Cell Expansion Revenue Market Share by Player in 2024
Figure 19. Others Revenue Market Share by Player in 2024
Figure 20. Global Cell Expansion Service Revenue Market Share by Type (2020-2031)
Figure 21. Global Cell Expansion Service Revenue Market Share by Application (2020-2031)
Figure 22. North America Cell Expansion Service Revenue YoY (2020-2031) & (US$ Million)
Figure 23. North America Top 5 Players Cell Expansion Service Revenue (US$ Million) in 2024
Figure 24. North America Cell Expansion Service Revenue (US$ Million) by Type (2020 - 2031)
Figure 25. North America Cell Expansion Service Revenue (US$ Million) by Application (2020-2031)
Figure 26. US Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 27. Canada Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 28. Mexico Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 29. Europe Cell Expansion Service Revenue YoY (2020-2031) & (US$ Million)
Figure 30. Europe Top 5 Players Cell Expansion Service Revenue (US$ Million) in 2024
Figure 31. Europe Cell Expansion Service Revenue (US$ Million) by Type (2020-2031)
Figure 32. Europe Cell Expansion Service Revenue (US$ Million) by Application (2020-2031)
Figure 33. Germany Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 34. France Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 35. U.K. Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 36. Italy Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 37. Russia Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 38. Asia-Pacific Cell Expansion Service Revenue YoY (2020-2031) & (US$ Million)
Figure 39. Asia-Pacific Top 8 Players Cell Expansion Service Revenue (US$ Million) in 2024
Figure 40. Asia-Pacific Cell Expansion Service Revenue (US$ Million) by Type (2020-2031)
Figure 41. Asia-Pacific Cell Expansion Service Revenue (US$ Million) by Application (2020-2031)
Figure 42. Indonesia Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 43. Japan Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 44. South Korea Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 45. Australia Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 46. India Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 47. Indonesia Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 48. Vietnam Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 49. Malaysia Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 50. Philippines Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 51. Singapore Cell Expansion Service Revenue (2020-2031) & (US$ Million)
Figure 52. Central and South America Cell Expansion Service Revenue YoY (2020-2031) & (US$ Million)
Figure 53. Central and South America Top 5 Players Cell Expansion Service Revenue (US$ Million) in 2024
Figure 54. Central and South America Cell Expansion Service Revenue (US$ Million) by Type (2020-2031)
Figure 55. Central and South America Cell Expansion Service Revenue (US$ Million) by Application (2020-2031)
Figure 56. Brazil Cell Expansion Service Revenue (2020-2025) & (US$ Million)
Figure 57. Argentina Cell Expansion Service Revenue (2020-2025) & (US$ Million)
Figure 58. Middle East and Africa Cell Expansion Service Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Middle East and Africa Top 5 Players Cell Expansion Service Revenue (US$ Million) in 2024
Figure 60. South America Cell Expansion Service Revenue (US$ Million) by Type (2020-2031)
Figure 61. Middle East and Africa Cell Expansion Service Revenue (US$ Million) by Application (2020-2031)
Figure 62. GCC Countries Cell Expansion Service Revenue (2020-2025) & (US$ Million)
Figure 63. Israel Cell Expansion Service Revenue (2020-2025) & (US$ Million)
Figure 64. Egypt Cell Expansion Service Revenue (2020-2025) & (US$ Million)
Figure 65. South Africa Cell Expansion Service Revenue (2020-2025) & (US$ Million)
Figure 66. Cell Expansion Service Industry Chain Mapping
Figure 67. Channels of Distribution (Direct Vs Distribution)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed
